OSE Immunotherapeutics to Present at Annual Sachs Immuno-Oncology: BD&L and Investment Forum

Dominique Costantini, CEO of OSE Immunotherapeutics, will provide an overview of the Company, its most recent accomplishments and future growth steps. She will focus on its original immuno-oncology portfolio…